Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis

Rossi S, Studer V, Moscatelli A, Centonze D (2013)
PLoS ONE 8(6).

Journal Article | Published | English

No fulltext has been uploaded

Author
; ; ;
Publishing Year
ISSN
eISSN
PUB-ID

Cite this

Rossi S, Studer V, Moscatelli A, Centonze D. Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE. 2013;8(6).
Rossi, S., Studer, V., Moscatelli, A., & Centonze, D. (2013). Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE, 8(6).
Rossi, S., Studer, V., Moscatelli, A., and Centonze, D. (2013). Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE 8.
Rossi, S., et al., 2013. Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE, 8(6).
S. Rossi, et al., “Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis”, PLoS ONE, vol. 8, 2013.
Rossi, S., Studer, V., Moscatelli, A., Centonze, D.: Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis. PLoS ONE. 8, (2013).
Rossi, Silvia, Studer, Valeria, Moscatelli, Alessandro, and Centonze, Diego. “Opposite Roles of NMDA Receptors in Relapsing and Primary Progressive Multiple Sclerosis”. PLoS ONE 8.6 (2013).
This data publication is cited in the following publications:
This publication cites the following data publications:

7 Citations in Europe PMC

Data provided by Europe PubMed Central.

Influence of Genetic Variants of the N-Methyl-D-Aspartate Receptor on Emotion and Social Behavior in Adolescents.
Lee LC, Cho YC, Lin PJ, Yeh TC, Chang CY, Yeh TK., Neural Plast. 2016(), 2016
PMID: 26819771
Neural Plasticity in Multiple Sclerosis: The Functional and Molecular Background.
Ksiazek-Winiarek DJ, Szpakowski P, Glabinski A., Neural Plast. 2015(), 2015
PMID: 26229689
T helper 9 cells induced by plasmacytoid dendritic cells regulate interleukin-17 in multiple sclerosis.
Ruocco G, Rossi S, Motta C, Macchiarulo G, Barbieri F, De Bardi M, Borsellino G, Finardi A, Grasso MG, Ruggieri S, Gasperini C, Furlan R, Centonze D, Battistini L, Volpe E., Clin. Sci. 129(4), 2015
PMID: 25700150
Role of amyloid-β CSF levels in cognitive deficit in MS.
Gentile A, Mori F, Bernardini S, Centonze D., Clin. Chim. Acta 449(), 2015
PMID: 25659291
Disability in multiple sclerosis: when synaptic long-term potentiation fails.
Weiss S, Mori F, Rossi S, Centonze D., Neurosci Biobehav Rev 43(), 2014
PMID: 24726576

111 References

Data provided by Europe PubMed Central.

A normative study on visual reaction times and two Stroop colour-word tests.
Barbarotto R, Laiacona M, Frosio R, Vecchio M, Farinato A, Capitani E., Ital J Neurol Sci 19(3), 1998
PMID: 10933471
Cognitive function in primary progressive and transitional progressive multiple sclerosis: a controlled study with MRI correlates.
Camp SJ, Stevenson VL, Thompson AJ, Miller DH, Borras C, Auriacombe S, Brochet B, Falautano M, Filippi M, Herisse-Dulo L, Montalban X, Parrcira E, Polman CH, De Sa J, Langdon DW., Brain 122 ( Pt 7)(), 1999
PMID: 10388799
Cognitive impairment and its relation with disease measures in mildly disabled patients with relapsing-remitting multiple sclerosis: baseline results from the Cognitive Impairment in Multiple Sclerosis (COGIMUS) study.
Patti F, Amato MP, Trojano M, Bastianello S, Tola MR, Goretti B, Caniatti L, Di Monte E, Ferrazza P, Brescia Morra V, Lo Fermo S, Picconi O, Luccichenti G; COGIMUS Study Group, Patti F, Lo Fermo S, Vecchio R, Maimone D, Messina S, Gasperini C, Orefice V, Brescia Morra V, Florio C, Amato MP, Goretti B, Portaccio E, Zipoli V, Bertolotto A, Bramanti P, Sessa E, Centonze D, Cottone S, Salemi G, Falcini M, Gallo P, Perini P, Gigli GL, Giuliani G, Grimaldi LM, Murri L, Lugaresi A, Monaco F, Montanari E, Motti L, Neri S, Paciello M, Provinciali L, Ragno M, Rosati G, Ruggieri S, Tola MR, Caniatti L, Tonali P, Batocchi AP, Trojano M, Di Monte E, De Caro MF, Ghezzi A, Zaffaroni M, Zolo P, Zorzon M, Signorino M, Scarpini E, Durelli L, Carolei A, Todaro M, Spitaleri D, Tartaglione A., Mult. Scler. 15(7), 2009
PMID: 19542262
Cognitive impairment in multiple sclerosis.
Patti F., Mult. Scler. 15(1), 2009
PMID: 18805842
Potential role of IL-13 in neuroprotection and cortical excitability regulation in multiple sclerosis.
Rossi S, Mancino R, Bergami A, Mori F, Castelli M, De Chiara V, Studer V, Mataluni G, Sancesario G, Parisi V, Kusayanagi H, Bernardi G, Nucci C, Bernardini S, Martino G, Furlan R, Centonze D., Mult. Scler. 17(11), 2011
PMID: 21677024
Corticocortical inhibition in human motor cortex.
Kujirai T, Caramia MD, Rothwell JC, Day BL, Thompson PD, Ferbert A, Wroe S, Asselman P, Marsden CD., J. Physiol. (Lond.) 471(), 1993
PMID: 8120818
Automated genotyping using the DNA MassArray technology.
Jurinke C, van den Boom D, Cantor CR, Koster H., Methods Mol. Biol. 187(), 2002
PMID: 12013745
A simple sequentially rejective multiple test procedure
AUTHOR UNKNOWN, 1979
MDM2 SNP309 and TP53 Arg72Pro interact to alter therapy-related acute myeloid leukemia susceptibility.
Ellis NA, Huo D, Yildiz O, Worrillow LJ, Banerjee M, Le Beau MM, Larson RA, Allan JM, Onel K., Blood 112(3), 2008
PMID: 18426989

AUTHOR UNKNOWN, 0
Analysis of multiple candidate genes in association with phenotypes of multiple sclerosis.
Sombekke MH, Arteta D, van de Wiel MA, Crusius JB, Tejedor D, Killestein J, Martinez A, Pena AS, Polman CH, Uitdehaag BM., Mult. Scler. 16(6), 2010
PMID: 20378664

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Sources

PMID: 23840674
PubMed | Europe PMC

Search this title in

Google Scholar